Literature DB >> 27194092

Coronary artery disease: Ceramides predict CV death in stable CAD and ACS.

Karina Huynh.   

Abstract

Entities:  

Year:  2016        PMID: 27194092     DOI: 10.1038/nrcardio.2016.81

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol.

Authors:  Reijo Laaksonen; Kim Ekroos; Marko Sysi-Aho; Mika Hilvo; Terhi Vihervaara; Dimple Kauhanen; Matti Suoniemi; Reini Hurme; Winfried März; Hubert Scharnagl; Tatjana Stojakovic; Efthymia Vlachopoulou; Marja-Liisa Lokki; Markku S Nieminen; Roland Klingenberg; Christian M Matter; Thorsten Hornemann; Peter Jüni; Nicolas Rodondi; Lorenz Räber; Stephan Windecker; Baris Gencer; Eva Ringdal Pedersen; Grethe S Tell; Ottar Nygård; Francois Mach; Juha Sinisalo; Thomas F Lüscher
Journal:  Eur Heart J       Date:  2016-04-28       Impact factor: 29.983

  1 in total
  3 in total

1.  Getting to the heart of the sphingolipid riddle.

Authors:  Britany A Law; William D Hancock; L Ashley Cowart
Journal:  Curr Opin Physiol       Date:  2017-12-13

2.  Plasma sphingolipids and depressive symptoms in coronary artery disease.

Authors:  Adam Dinoff; Mahwesh Saleem; Nathan Herrmann; Michelle M Mielke; Paul I Oh; Swarajya Lakshmi Vattem Venkata; Norman J Haughey; Krista L Lanctôt
Journal:  Brain Behav       Date:  2017-09-26       Impact factor: 2.708

3.  Plasma Ceramides in Relation to Coronary Plaque Characterization Determined by Optical Coherence Tomography.

Authors:  Weili Pan; Hui Dong; Rong Sun; Linlin Zhao; Meng Sun; Longyan Li; Xianghao Yu; Jinxin Liu; Jianjun Wu; Fan Yang; Bo Yu
Journal:  J Cardiovasc Transl Res       Date:  2020-03-24       Impact factor: 4.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.